- Price
- $19.61
- Day
- -5.43%
- Mkt Cap
- $262.44M
- 52W Range
- $7.92 – $20.60
- Volume
- 224.9K
- Beta
- 0.23
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript
Read full article
Anika Therapeutics NASDAQ: ANIK reported higher second-quarter revenue, expanded gross margin and its strongest adjusted EBITDA performance since 2020, as international commercial growth and manufacturing improvements supported profitability.
Read full article
BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter 2026 financial results before the opening of the market on Wednesday, July 29, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
Read full article